doi: 10.1161/CIRCULATIONAHA.105.560128
(Circulation. 2005;112:3088-3096.)
© 2005 American Heart Association, Inc.
Epidemiology |
Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease
A Meta-Analysis
From the Division of Internal Medicine (N.A.K.), Division of Cardiology (C.R.T.), and Division of Nephrology (A.L.), University of British Columbia, and the Division of Nephrology, University of Calgary, Calgary (B.R.H.), and the Division of Nephrology, University of Alberta, Edmonton (M.T.), Alberta, Canada.
Correspondence to Nadia A. Khan, MD, 620-B 1081 Burrard St, Vancouver, BC, Canada, V6Z 1Y6 E-mail nakhan{at}shaw.ca
Received May 4, 2005; accepted July 25, 2005.
Background— The prognostic usefulness of troponin enzymes in end-stage renal disease (ESRD) patients is controversial. To resolve this uncertainty of troponin as a prognostic tool, we conducted a systematic review to quantify the association between elevated troponin I or T and long-term total mortality among ESRD patients not suspected of having acute coronary syndrome.
Methods and Results— We conducted an unrestricted search from the MEDLINE, EMBASE, and DARE bibliographic databases to December 2004 using the terms troponin.mp. or exp troponin and exp kidney, exp renal, exp kidney disease exp renal replacement therapy. We also manually searched review articles and bibliographies to supplement the search. Studies were included if they were prospective observational studies, used cardiac-specific troponin assays, and evaluated long-term risk of death or cardiac events for asymptomatic ESRD patients. Two authors independently abstracted data on study and patient characteristics. Studies findings were stratified according to troponin T or I levels. We used a random-effects model to pool study results and tested for heterogeneity using 
2 testing and used funnel-plot inspection to evaluate the presence of publication bias. Data from 28 studies (3931 patients) published between 1999 and December 2004 were included in this review. Patients received dialysis for a median duration of 4 years, with a mean follow-up of 23 months. From the pooled analysis, elevated troponin T (>0.1 ng/mL) was significantly associated with increased all-cause mortality (relative risk, 2.64; 95% CI, 2.17 to 3.20). Although the prognostic effect sizes were all consistent with a positive relationship between troponin T and mortality, there was significant heterogeneity in the magnitude of these effect sizes (P=0.015). The funnel plot showed evidence of publication bias. Elevated troponin T was also strongly associated with increased cardiac death. Studies evaluating troponin I included a wide variety of assays and differing cut points, rendering synthesis of the study findings difficult.
Conclusions— Elevated troponin T (>0.1 ng/mL) identifies a subgroup of ESRD patients who have poor survival and a high risk of cardiac death despite being asymptomatic. These findings suggest that troponin T is a promising risk stratification tool and may help frame therapeutic decisions. The clinical interpretation of elevated troponin I levels, however, remain unclear, largely because of the lack of standardization of assays.
CLINICAL PERSPECTIVE
This article has been cited by other articles:
 |
|
 |
|
  K. M. Janata, J. M. Leitner, N. Holzer-Richling, A. Janata, A. N. Laggner, and B. Jilma Troponin T predicts in-hospital and 1-year mortality in patients with pulmonary embolism Eur. Respir. J., December 1, 2009; 34(6): 1357 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Paniagua, M.-d.-J. Ventura, M. Avila-Diaz, H. Hinojosa-Heredia, A. Mendez-Duran, A. Cueto-Manzano, A. Cisneros, A. Ramos, C. Madonia-Juseino, F. Belio-Caro, et al. NT-proBNP, Fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients Nephrol. Dial. Transplant., August 12, 2009; (2009) gfp395v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Blendea, M Blendea, J Banker, and C A McPherson Troponin T elevation after implanted defibrillator discharge predicts survival Heart, July 15, 2009; 95(14): 1153 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H Jacobs, J. van de Kerkhof, A. M Mingels, V. W Kleijnen, F. M van der Sande, W. K Wodzig, J. P Kooman, and M. P van Dieijen-Visser Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays Ann Clin Biochem, July 1, 2009; 46(4): 283 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A Roberts, D. L Hare, N. Macmillan, S. Ratnaike, K. Sikaris, and F. L Ierino Serial increased cardiac troponin T predicts mortality in asymptomatic patients treated with chronic haemodialysis Ann Clin Biochem, July 1, 2009; 46(4): 291 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. O Collinson and D. C Gaze Cardiac troponins in patients with renal failure: what are we measuring and when should we measure it? Ann Clin Biochem, July 1, 2009; 46(4): 269 - 270. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kuhn, T. Addona, H. Keshishian, M. Burgess, D.R. Mani, R. T. Lee, M. S. Sabatine, R. E. Gerszten, and S. A. Carr Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry Clin. Chem., June 1, 2009; 55(6): 1108 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. W. Kang, H. J. Na, S. M. Hong, S. K. Shin, S.-W. Kang, K. H. Choi, H. Y. Lee, D.-S. Han, and S. H. Han Prognostic value of elevated cardiac troponin I in ESRD patients with sepsis Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1568 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. O. Burton, H. J. Jefferies, N. M. Selby, and C. W. McIntyre Hemodialysis-Induced Cardiac Injury: Determinants and Associated Outcomes Clin. J. Am. Soc. Nephrol., May 1, 2009; 4(5): 914 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hayashi, Y. Obi, T. Kimura, K.-i. Iio, S. Sumitsuji, Y. Takeda, Y. Nagai, and E. Imai Cardiac troponin T predicts occult coronary artery stenosis in patients with chronic kidney disease at the start of renal replacement therapy Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2936 - 2942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y.-M. Wang and K.-N. Lai Use of Cardiac Biomarkers in End-Stage Renal Disease J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1643 - 1652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C Gaze and P. O Collinson Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance Ann Clin Biochem, July 1, 2008; 45(4): 349 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. McCullough Coronary Artery Disease Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 611 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yee-Moon Wang, C. Wai-Kei Lam, M. Wang, I. Hiu-Shuen Chan, W. B. Goggins, C.-M. Yu, S.-F. Lui, and J. E Sanderson Prognostic Value of Cardiac Troponin T Is Independent of Inflammation, Residual Renal Function, and Cardiac Hypertrophy and Dysfunction in Peritoneal Dialysis Patients Clin. Chem., May 1, 2007; 53(5): 882 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. S. Apple, A. S. Jaffe, and C. A. Herzog Letter Regarding Article by Khan et al, "Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis" Circulation, May 23, 2006; 113(20): e775 - e775. [Full Text] [PDF]
|
|
|
|
|
|
N. A. Khan, B. R. Hemmelgarn, M. Tonelli, C. R. Thompson, and A. Levin Response to Letter Regarding Article by Khan et al, "Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis" Circulation, May 23, 2006; 113(20): e776 - e776. [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Henry, D. Satran, B. Lindgren, C. Adkinson, C. I. Nicholson, and T. D. Henry Myocardial Injury and Long-term Mortality Following Moderate to Severe Carbon Monoxide Poisoning JAMA, January 25, 2006; 295(4): 398 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Lauer Cardiac Troponins and Renal Failure: The Evolution of a Clinical Test Circulation, November 15, 2005; 112(20): 3036 - 3037. [Full Text] [PDF]
|
|